Market Cap 92.41M
Revenue (ttm) 127.49M
Net Income (ttm) -39.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -30.78%
Debt to Equity Ratio -0.07
Volume 45,500
Avg Vol 96,682
Day's Range N/A - N/A
Shares Out 57.40M
Stochastic %K 14%
Beta 2.02
Analysts Sell
Price Target $6.50

Company Profile

Ispire Technology Inc. researches, develops, designs, commercializes, sells, markets, and distributes e-cigarettes and cannabis vaping products worldwide under the Ispire and Aspire brands. The company was founded in 2010 and is headquartered in Los Angeles, California. Ispire Technology Inc. is a subsidiary of Pride Worldwide Investment Limited.

Industry: Tobacco
Sector: Consumer Defensive
Phone: 310 742 9975
Address:
19700 Magellan Drive, Los Angeles, United States
jboii
jboii Jun. 3 at 12:44 AM
$CHUC $ISPR When investors cite JUUL's $38B valuation, they're often using it as a proof that the market can place enormous values on nicotine-platform companies. The more difficult question is whether today's regulatory shifts make a future nicotine company more valuable because the pathway is clearer, or less valuable because the market is now more constrained and regulated. My thesis is that the clarity itself creates value—especially for $CHUC, who already invested heavily in PMTAs and compliance before the market recognized their importance.
0 · Reply
jboii
jboii Jun. 3 at 12:42 AM
$CHUC $ISPR The famous ~$38 billion valuation came when Altria Group invested in JUUL in 2018. For CHUC, the bull thesis is different. It's not: "We dominate the vape market today." It's closer to: "We own a large portfolio of regulatory assets that may become substantially more valuable under an evolving FDA framework." Those are not valued the same way- but a $38B valuation would imply that the buyer believes CHUC has become one of the most strategically important nicotine assets in the world.
1 · Reply
jboii
jboii May. 22 at 4:42 AM
0 · Reply
topstockalerts
topstockalerts May. 19 at 10:06 PM
$ISPR this chart has become surprisingly hard to argue with.
0 · Reply
topstockalerts
topstockalerts May. 19 at 9:28 PM
Top Gainers PT2 $GIPR $MTVA $SVRN $CODX $ISPR
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 19 at 9:16 PM
$ISPR Great piece that accurately captures ISPR's current position. So if you want to refresh your understanding of ISPR or learn about ISPR for the first time, this is essential reading. https://everyticker.com/quote/ISPR/analysis/ispire-technology-s-triple-threat-malaysia-manufacturing-age-gating-tech-and-financial-turnaround-nasdaq-ispr
0 · Reply
jboii
jboii May. 19 at 5:25 PM
0 · Reply
jboii
jboii May. 18 at 3:19 PM
$CHUC $ISPR $MO https://finance.yahoo.com/markets/stocks/articles/americas-second-largest-c-store-130000758.html
0 · Reply
SuperGreenToday
SuperGreenToday May. 14 at 5:27 PM
$ISPR Share Price: $1.69 Contract Selected: Aug 21, 2026 $2.5 Calls Buy Zone: $0.13 – $0.16 Target Zone: $0.24 – $0.29 Potential Upside: 76% ROI Time to Expiration: 98 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jboii
jboii May. 12 at 6:41 PM
1 · Reply
Latest News on ISPR
Ispire Technology Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 23 days ago

Ispire Technology Proxy statement: Proxy filing


Ispire Technology Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 23 days ago

Ispire Technology Proxy statement: Proxy filing


Ispire Technology reports Q3 EPS (17c) vs. (19c) last year

2026-05-07T14:34:23.000Z - 4 weeks ago

Ispire Technology reports Q3 EPS (17c) vs. (19c) last year


Ispire Technology Earnings Call Transcript: Q3 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Ispire Technology Earnings Call Transcript: Q3 2026


Ispire Technology Earnings release: Q3 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Ispire Technology Earnings release: Q3 2026


Ispire Technology Quarterly report: Q3 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Ispire Technology Quarterly report: Q3 2026


Ispire Technology Earnings Call Transcript: Q2 2026

Feb 6, 2026, 8:00 AM EST - 4 months ago

Ispire Technology Earnings Call Transcript: Q2 2026


Ispire Technology Earnings release: Q2 2026

Feb 6, 2026, 8:00 AM EST - 4 months ago

Ispire Technology Earnings release: Q2 2026


Ispire Technology Quarterly report: Q2 2026

Feb 6, 2026, 8:00 AM EST - 4 months ago

Ispire Technology Quarterly report: Q2 2026


Ispire Technology reports Q2 (12c) vs. (14c) last year

2026-02-06T12:10:29.000Z - 4 months ago

Ispire Technology reports Q2 (12c) vs. (14c) last year


Ispire Technology Slides: Investor presentation

Nov 19, 2025, 7:00 AM EST - 7 months ago

Ispire Technology Slides: Investor presentation


Ispire Technology Earnings Call Transcript: Q1 2026

Nov 6, 2025, 8:00 AM EST - 7 months ago

Ispire Technology Earnings Call Transcript: Q1 2026


Ispire Technology Quarterly report: Q1 2026

Nov 6, 2025, 8:00 AM EST - 7 months ago

Ispire Technology Quarterly report: Q1 2026


Ispire Technology Earnings release: Q1 2026

Nov 6, 2025, 8:00 AM EST - 7 months ago

Ispire Technology Earnings release: Q1 2026


Ispire Technology Earnings Call Transcript: Q4 2025

Sep 16, 2025, 8:00 AM EDT - 9 months ago

Ispire Technology Earnings Call Transcript: Q4 2025


Ispire Technology Earnings release: Q4 2025

Sep 16, 2025, 8:00 AM EDT - 9 months ago

Ispire Technology Earnings release: Q4 2025


Ispire Technology Annual report: Q4 2025

Sep 16, 2025, 8:00 AM EDT - 9 months ago

Ispire Technology Annual report: Q4 2025


Ispire Technology names Jay Yu as CFO, reduces workforce

2025-05-15T20:36:21.000Z - 1 year ago

Ispire Technology names Jay Yu as CFO, reduces workforce


Ispire Technology Proxy statement: Proxy Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Ispire Technology Proxy statement: Proxy Filing


Ispire Technology Earnings Call Transcript: Q3 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Ispire Technology Earnings Call Transcript: Q3 2025


Ispire Technology Earnings release: Q3 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Ispire Technology Earnings release: Q3 2025


Ispire Technology Quarterly report: Q3 2025

May 12, 2025, 8:00 AM EDT - 1 year ago

Ispire Technology Quarterly report: Q3 2025


Ispire Technology Earnings Call Transcript: Q2 2025

Feb 10, 2025, 8:00 AM EST - 1 year ago

Ispire Technology Earnings Call Transcript: Q2 2025


Ispire Technology Earnings release: Q2 2025

Feb 10, 2025, 8:00 AM EST - 1 year ago

Ispire Technology Earnings release: Q2 2025


Ispire Technology Quarterly report: Q2 2025

Feb 10, 2025, 8:00 AM EST - 1 year ago

Ispire Technology Quarterly report: Q2 2025


Ispire Technology reports Q2 EPS (14c) vs. (7c) last year

2025-02-10T12:15:24.000Z - 1 year ago

Ispire Technology reports Q2 EPS (14c) vs. (7c) last year


Ispire Technology announces $10M stock repurchase program

2025-01-22T13:06:27.000Z - 1 year ago

Ispire Technology announces $10M stock repurchase program


Ispire Technology Inc. Announces Stock Repurchase Program

Jan 22, 2025, 8:00 AM EST - 1 year ago

Ispire Technology Inc. Announces Stock Repurchase Program


Ispire Technology Earnings Call Transcript: Q1 2025

Nov 11, 2024, 8:00 AM EST - 1 year ago

Ispire Technology Earnings Call Transcript: Q1 2025


Ispire Technology Quarterly report: Q1 2025

Nov 11, 2024, 8:00 AM EST - 1 year ago

Ispire Technology Quarterly report: Q1 2025


Ispire Technology Earnings release: Q1 2025

Nov 11, 2024, 8:00 AM EST - 1 year ago

Ispire Technology Earnings release: Q1 2025


Ispire Technology reports Q1 EPS (10c) vs. (2c) last year

2024-11-11T12:08:06.000Z - 1 year ago

Ispire Technology reports Q1 EPS (10c) vs. (2c) last year


Ispire Technology Earnings Call Transcript: Q4 2024

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Ispire Technology Earnings Call Transcript: Q4 2024


Ispire Technology Annual report: Q4 2024

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Ispire Technology Annual report: Q4 2024


Ispire Technology Earnings release: Q4 2024

Sep 26, 2024, 8:00 AM EDT - 1 year ago

Ispire Technology Earnings release: Q4 2024


Ispire Technology Registration statement: Registration Filing

Jul 17, 2024, 8:00 AM EDT - 2 years ago

Ispire Technology Registration statement: Registration Filing


jboii
jboii Jun. 3 at 12:44 AM
$CHUC $ISPR When investors cite JUUL's $38B valuation, they're often using it as a proof that the market can place enormous values on nicotine-platform companies. The more difficult question is whether today's regulatory shifts make a future nicotine company more valuable because the pathway is clearer, or less valuable because the market is now more constrained and regulated. My thesis is that the clarity itself creates value—especially for $CHUC, who already invested heavily in PMTAs and compliance before the market recognized their importance.
0 · Reply
jboii
jboii Jun. 3 at 12:42 AM
$CHUC $ISPR The famous ~$38 billion valuation came when Altria Group invested in JUUL in 2018. For CHUC, the bull thesis is different. It's not: "We dominate the vape market today." It's closer to: "We own a large portfolio of regulatory assets that may become substantially more valuable under an evolving FDA framework." Those are not valued the same way- but a $38B valuation would imply that the buyer believes CHUC has become one of the most strategically important nicotine assets in the world.
1 · Reply
jboii
jboii May. 22 at 4:42 AM
0 · Reply
topstockalerts
topstockalerts May. 19 at 10:06 PM
$ISPR this chart has become surprisingly hard to argue with.
0 · Reply
topstockalerts
topstockalerts May. 19 at 9:28 PM
Top Gainers PT2 $GIPR $MTVA $SVRN $CODX $ISPR
0 · Reply
NVDAMillionaire
NVDAMillionaire May. 19 at 9:16 PM
$ISPR Great piece that accurately captures ISPR's current position. So if you want to refresh your understanding of ISPR or learn about ISPR for the first time, this is essential reading. https://everyticker.com/quote/ISPR/analysis/ispire-technology-s-triple-threat-malaysia-manufacturing-age-gating-tech-and-financial-turnaround-nasdaq-ispr
0 · Reply
jboii
jboii May. 19 at 5:25 PM
0 · Reply
jboii
jboii May. 18 at 3:19 PM
$CHUC $ISPR $MO https://finance.yahoo.com/markets/stocks/articles/americas-second-largest-c-store-130000758.html
0 · Reply
SuperGreenToday
SuperGreenToday May. 14 at 5:27 PM
$ISPR Share Price: $1.69 Contract Selected: Aug 21, 2026 $2.5 Calls Buy Zone: $0.13 – $0.16 Target Zone: $0.24 – $0.29 Potential Upside: 76% ROI Time to Expiration: 98 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
jboii
jboii May. 12 at 6:41 PM
1 · Reply
jboii
jboii May. 12 at 5:33 PM
$CHUC $ISPR “Glas Inc. is based in Los Angeles. The products the FDA just authorized are American-made. RFK Jr.’s critique of the previous regulatory environment was explicitly framed around the harm done to U.S. manufacturers. The crackdown on Chinese illegal vapes creates market space for domestic products. The authorization of an American company’s flavored products fills some of that space with something legal and regulated.”
2 · Reply
jboii
jboii May. 12 at 5:31 PM
$CHUC $ISPR https://spinfuel.com/why-rfk-jr-and-the-fda-american-vapers/
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 12:50 PM
$ISPR Q3 '26 Earnings Results & Recap Ispire Technology Inc. plans to achieve cash flow positive status in the second half of calendar year 2026, reflecting business stabilization and strategic repositioning.
0 · Reply
Marci911
Marci911 May. 7 at 11:10 AM
$CHUC A quick CHUC summary. On Tuesday the FDA approved, for the very first time, 2 flavored PMTAs (legal permits required to sell to public). Fda approved them because the vapes offer age gating..preventing youth access. At the Keller Symposium, industry experts immediately gave privately held Glas a $1B valuation. What this means for CHUC. After waiting patiently for over 5 years, and because Charlie's already has a deal with IKE (another AG vape device co) which is partially owned by $ISPR, to launch (estimated 10 to 15) flavored pmtas with ag in the near term. If you read the quote from Henry, he thinks 10 to 15 ag pmtas could be worth more than $2B 2 key points. Glas getting approved opened up the door...and I cant see how the govt wouldn't approve another player..they wouldn't want to turn Glas into a monopoly.
2 · Reply
TallahasseeTalisman
TallahasseeTalisman May. 7 at 9:48 AM
$ISPR is there a pm earnings today ? What it says on robinhood ....if tru what are we thinking ?
0 · Reply
jboii
jboii May. 6 at 7:42 PM
1 · Reply
jorgegb
jorgegb May. 6 at 2:06 AM
$CHUC The Reddit post from r/pennystocks said it perfectly: “The value is a flavor PMTA…and CHUC has 678 of them.” Here’s what most people are missing, IKE Tech is a joint venture of three companies; Ispire $ISPR, Berify, and Chemular. CHUC’s own board member Dr. Ed Carmines is Chief Scientific Officer at Chemular, one of IKE’s three founding partners. He’s not just on the board. He built part of the technology. It’s clear now why he kept buying CHUC stock at $0.28 and $0.29, above today’s price. Today the FDA authorized the first ever non-tobacco, non-menthol flavored vapes, using age-gating technology as the pathway. The exact technology CHUC licensed from IKE in January 2026. Age-gating devices without PMTAs are worthless. PMTAs without age-gating can’t get flavored approval. CHUC has both. (678 PMTAs + IKE deal signed). And every one of those 678 PMTAs can be amended to incorporate IKE age-gating. Now, we just wait for the NYSE American uplist. Long $CHUC $ISPR $MO $BTI
1 · Reply
jboii
jboii May. 5 at 6:36 PM
$CHUC $BTI $ISPR $MO https://www.reuters.com/legal/litigation/trump-pressures-fdas-makary-approve-flavored-vapes-wsj-reports-2026-05-05/
0 · Reply
jboii
jboii May. 2 at 2:23 AM
$CHUC $ISPR @FatherFauci If they dilute, they’re diluting themselves too (they own ~50% of common stock)— so the only logical explanation would be that YES, the SBX American filled products actually are performing that well (as the 2025 financials clearly reflect)… the major catalyst is the nicotine line. For metatine- hard to disagree in terms of future legality, but they’re certainly gaining attention. 169% top line growth YoY with most earned in the second half.. Hmm, idk bout you but I’m excited for Q1. Issuing more shares grants them capital (and quickly) that they could use to expand & scale operations. Potential MGOs issued to them by the FDA would create demand they wouldn’t have the capacity to fill right now.. they have 600+ PMTAs with the potential of being granted an MGO.. Not to mention the joint venture w IKE Tech for age-gating tech.. ..And the new leadership roles at the FDA & CDC.. The process has been stagnant for 5 years, but we’re finally seeing movement…
1 · Reply
jboii
jboii May. 2 at 2:13 AM
$CHUC $ISPR @FatherFauci If they dilute, they’re diluting themselves too (they own ~50% of common stock)— so the only logical explanation would be that YES, the SBX American filled products actually are performing that well (as the 2025 financials clearly reflect)… the major catalyst is the nicotine line. For metatine- hard to disagree in terms of future legality, but they’re certainly gaining attention. 169% top line growth YoY with most earned in the second half.. Hmm, idk bout you but I’m excited for Q1. Issuing more shares grants them capital (and quickly) that they could use to expand & scale operations. Potential MGOs issued to them by the FDA would create demand they wouldn’t have the capacity to fill right now.. they have 600+ PMTAs with the potential of being granted an MGO.. Not to mention the joint venture w IKE Tech for age-gating tech.. ..And the new leadership roles at the FDA & CDC.. The process has been stagnant for 5 years, but we’re finally seeing movement..
0 · Reply
Marci911
Marci911 May. 1 at 2:28 PM
$CHUC British American Tobacco did not spend up to $11.7 million buying into Charlie’s PMTA-linked assets because it believed flavored regulatory filings were meaningless. Now, with Charlie’s actively upgrading its remaining filings around FDA youth concerns and federal courts beginning to challenge the FDA’s flavored denial framework, investors have to ask a much bigger question. Did Big Tobacco already place its bet on Charlie’s PMTA optionality before Wall Street understood what was sitting there? $MO $PM $TPB $ISPR
0 · Reply
Surfratt
Surfratt May. 1 at 2:49 AM
0 · Reply